VCM
IBB icon

Vivaldi Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Vivaldi Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,239
Closed -$283K – 294
2025
Q2 		$283K Sell
2,239
-72
-3% -$8.84K 0.04% 229
2025
Q1 		$296K Sell
2,311
-752
-25% -$102K 0.05% 207
2024
Q4 		$424K Sell
3,063
-1,725
-36% -$243K 0.07% 163
2024
Q3 		$697K Buy
4,788
+6
+0.1% +$868 0.2% 90
2024
Q2 		$656K Buy
4,782
+100
+2% +$13.3K 0.19% 105
2024
Q1 		$625K Sell
4,682
-78
-2% -$10.7K 0.18% 108
2023
Q4 		$630K Sell
4,760
-112
-2% -$13.7K 0.19% 110
2023
Q3 		$596K Hold
4,872
– – 0.19% 99
2023
Q2 		$619K Hold
4,872
– – 0.19% 97
2023
Q1 		$629K Sell
4,872
-304
-6% -$39.8K 0.19% 99
2022
Q4 		$674K Buy
5,176
+1
+0% +$129 0.17% 119
2022
Q3 		$615K Buy
5,175
+498
+11% +$61.8K 0.17% 103
2022
Q2 		$550K Hold
4,677
– – 0.14% 118
2022
Q1 		$529K Sell
4,677
-663
-12% -$86.4K 0.14% 127
2021
Q4 		$815K Hold
5,340
– – 0.19% 95
2021
Q3 		$863K Buy
5,340
+2
+0% +$337 0.19% 89
2021
Q2 		$904K Buy
5,338
+565
+12% +$87K 0.18% 95
2021
Q1 		$714K Buy
4,773
+2,647
+125% +$420K 0.14% 116
2020
Q4 		$322K Buy
2,126
+621
+41% +$88.7K 0.07% 178
2020
Q3 		$212K Hold
1,505
– – 0.05% 230
2020
Q2 		$201K Buy
+1,505
New +$192K 0.04% 246
2019
Q3 		– Sell
-7,222
Closed -$788K – 237
2019
Q2 		$788K Sell
7,222
-4,870
-40% -$518K 0.21% 107
2019
Q1 		$1.35M Buy
12,092
+9,339
+339% +$1.02M 0.38% 70
2018
Q4 		$265K Buy
+2,753
New +$292K 0.11% 150

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vivaldi Capital Management's IBB Position: Q3 2025 in Review

Vivaldi Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 2,239 shares — an estimated $283K sold.

Vivaldi Capital Management first reported a position in IBB in Q4 2018 and held it in 24 quarters. The position peaked at $1.35M in Q1 2019. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Vivaldi Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Vivaldi Capital Management sold 2,239 iShares Biotechnology ETF shares in Q3 2025, an estimated $283K.
  • Vivaldi Capital Management first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 24 quarters.
  • Vivaldi Capital Management's iShares Biotechnology ETF position peaked at $1.35M in Q1 2019.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Vivaldi Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.